| abstract |
The present specification relates to a composition comprising ginsenoside Rb2 as an active ingredient. The composition of the present specification protects nerve cells from oxidative stress and exhibits an effect of inhibiting the death of nerve cells. In addition, it is possible to increase the expression of an antioxidant enzyme that inhibits apoptosis caused by an increase in oxidative stress in cells. Accordingly, the composition of the present specification may exhibit an effect of preventing, improving, or treating secondary diseases that may occur due to the death of nerve cells from oxidative stress, and thus may be used as a pharmaceutical or food composition. |